# Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223

> **NCT02981797** · — · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 10 (actual)

## Conditions studied

- Prostate Cancer
- Prostate Adenocarcinoma

## Interventions

- **OTHER:** Blood Collection During Standard of Care Treatment

## Key facts

- **NCT ID:** NCT02981797
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-22
- **Primary completion:** 2017-08-29
- **Final completion:** 2020-11-05
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-06-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02981797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02981797, "Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT02981797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*